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The regulation of the contractility and intratesticular 
pressure of rabbit testes was studied. The effects of, and 
interactions among, prostaglandins (PGs) E1 and F2a' testosterone, 
acetylcholine, epinephrine and norepinephrine were ascertained 
both in vitro and in vivo. All of these compounds, except for 
high concentrations of PGE1 and testosterone, stimulated the 
testicular capsule to contract. PGE1 at low concentrations 
potentiated the contractions produced by epinephrine and 
acetylcholine. Above l0- 7M, PGE1 inhibited contractions caused 
by PGF2a' epinephrine or acetylcholine. Testosterone inhibited 
contractions caused by PGF2 in vitro. a-
Preinjections of rabbits with the PG synthetase inhibitor, 
indomethacin, significantly reduced testicular contractility 
in vivo. A second inhibitor of PG synthetase, 5,8,11,14-eicosa-
tetraynoic acid (TYA), had no such effect. Reserpine failed to 
alter testicular contractions in vivo. Atte_!.llpts to stimulate 
the spermatic nerve electrically using Ag-AgCl electrodes did 
not alter intratesticular pressure. 
xiii 
Exposing male rabbits to females had no significant effect 
on testicular contractions in vivo or in vitro. Serum testosterone 
measurements were made after injections of indomethacin, TVA, 
reserpine and combinations of indomethacin and PGE1. No 
significant changes were noted among groups due to large 
variability. 
Intratesticular pressure showed spontaneous, rhythmical 
fluctuations in some preparations. Intravenous injections of 
norepinephrine increased overall pressure, whereas isoproterenol 
decreased it. The inhibition of rhythmical pressure changes 
after iv infusion of isoproterenol persisted at least half an 
hour. During this time norepinephrine failed to increase 
intratesticular pressure. 
( 107 pages) 
INTRODUCTION 
Prostaglandins (PGs) constitute a family of hormones derived 
from linoleic and arachidonic acid. They are unsaturated, acidic 
lipids, 20 carbons in length, that possess a cyclopentano ring 
with keto or hydroxyl substituents. Kurzrock and Lieb (1930) 
and Goldblatt (1933) noted both stimulatory and inhibitory 
influences of human seminal fluid on uterine strips. Von Euler 
(1936) found that extracts of semen and prostate glands of some 
species also affected blood pressure; he termed the responsible 
factor 11prostaglandin. 11 The isolation, crystallization and 
ultimate identification of the PGs (Nugteren et al., 1966) is 
discussed comprehensively by Bergstrom (1967). 
One of the original suggestions for a physiological function 
of PGs was that they might activate smooth muscle in ducts and 
facilitate emptying of accessory genital organs (Von Euler, 1936; 
Eliasson, 1959). Other roles might include maintenance of 
spermatozoal activity (Hawkins and Labrum, 1956), regulation of 
autonomic neuro-transmission (Hedqvist, 1973), and effects on the 
output of hypothalamic gonadotropins or gonadal steroids 
(Flack, 1973). 
A role for PGs in the testis was first investigated by Ellis 
and Baptista (1969). They found that PGA1 and PGE1 significantly 
reduced testosterone production in minced rat testes, and that 
2 
PGA1 decreased total androgen production. In addition, lipid 
peroxidation (which includes PG production) was subject to 
hormonal control, since hypophysectomy decrease,d output of 
peroxides. Antioxidants such as D-a-tocopherol had similar 
effects (Ellis and Baptista, 1969). Aging also increased lipid 
peroxidation in their study. Subsequent work showed that rat 
testes produce PGs from labelled precursors (Carpenter and 
Wiseman, 1970; Carpenter, Manning and Wiseman, 1971) as well as 
from unlabelled substrate (Ellis, Johnson and Hargrove, 1972; 
Ellis, 1972). Rabbit testes also contain PGs (Hargrove et al., 
1973; Seeley, 1973), as do swine testes (Michael, 1973). 
Testicular smooth muscle may be a target for PG activation. 
The capsule of rat and rabbit testes contracts in response to 
exogenously-administered autonomic agents (Davis, Langford and 
Kirby, 1970). The rabbit testis contracts spontaneously i..!}_ vitro 
and j_Q_ vivo (Davis and Langford, 1970). These spontaneous 
contractions appear to be mediated by prostaglandins i..!}_ vitro 
(Hargrove et al., 1973). The factors that control in vivo 
capsular activity probably include nerves in the rat (Bell and 
McLean, 1973) and the dog (Rikimaru et al., 1972) but not the 
human (Shirai, Suzuki and Rikimaru, 1973). Catecholamines of 
adrenal origin may also be important in regulating activity of 
the testicular capsule (Cross, 1958). Epinephrine, norepinephrine, 
acetylcholine and PGF2a all contract the testicular capsule 
(Davis and Langford, 1969a and b; Johnson, Hargrove and Ellis, 
1971), while PGE1 (Hargrove, Johnson and Ellis, 1971) and 
3 
testosterone (Seeley et al., 1972) inhibit it. The interactions 
of these agents may be important in the determination of sperm 
output, testicular blood flow, and return of lymphatic fluid to 
the body (Hargrove, Seeley and Ellis, 1973). 
REVIEW OF LITERATURE 
Pharmacology and physiology of the 
testicular capsule 
Physiological investigations concerning the smooth muscle 
of rabbit testicular capsules were begun by B. A. Cross (1959). 
The capsules contracted rhythmically when the testis was left 
4 
in the scrotal sac i~ vivo and contracted tonically after an iv 
infusion of norepinephrine. In addition, electrical stimulation 
of the sympathetic centers in the hypothalamus caused capsular 
contraction (Cross, 1958). With light microscopy smooth muscle 
cells were later observed in the tunica albuginea of testes from 
men and rabbits and found to have uneven distribution in the 
human capsule (Holstein, 1967). In addition, pressure fluctuations 
equal to 0.25 cm of water occurred, with a frequency of 0.7 per 
minute (Holstein and Weiss, 1967). These observations were 
corroborated for the rabbit and extended to the laboratory rat 
by Davis, Langford and Kirby, 1970; and Davis and Langford, 
1969a and b. 
The first pharmacological study of capsular smooth muscle 
indicated that acetylcholine and norepinephrine produced 
contractures of long duration (20 minutes) in isolated rat 
testicular capsules at concentrations of 10-8M or less (Davis and 
Langford, 1969a). These workers postulated, as did Holstein (1967) 
and Holstein and Weiss (1967), that such contractions might 
affect sperm transport. In more extensive studies, Davis and 
Langford (1970, 1971) noted that parasympathomimetic agents 
(carbachol and pilocarpine) and sympathomimetic agents 
(epinephrine and norepinephrine), as well as ganglionic stimu-
lating agents (tetramethyl ammonium), histamine, and BaC12 all 
produced contractile responses. Isoproterenol relaxed the 
capsule (Davis and Langford, 1971). Two layers of muscle were 
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found by microscopic examination, an outer longitudinal layer 
parallel to the longitudinal axis of the testes with a deeper 
circular layer (Davis and Langford, 1970). In reviews of their 
work, Davis, Langford and Kirby (1971) pointed out that radioactive 
lysine diffused from the outer to the inner compartment of 
isolated rat testes within 3-4 hours. They suggested that 
tissue fluid or testicular metabolites may move across the 
capsule similarly to lysine. Rabbit testes, in contrast to rat 
testes, evolved rhythmical contractions both i!l vitro and i!l vivo, 
but both showed similar responses to various pharmacological 
agents. Strips of human capsules from biopsy specimens also 
contracted autorhythmically i!l vitro (Davis and Langford, 1970). 
Examination of human capsules showed that the outer layer (tunica 
vaginalis visceral) was a serous membrane. The middle layer of 
the tunica albuginea consisted predominantly of smooth muscle, 
while the inner tunica vaginalis vasculosa was densely supplied 
with blood vessels (Langford and Heller, 1973). In the same study, 
neighboring muscle cells were shown to approach within 50 ~ of 
each other by way of cytoplasmic extensions. Such close 
connections may provide the anatomical basis for the concerted, 
autorhythmic contractions noted in both rabbit and human 
preparations. 
Other pharmacological agonists also affected rabbit 
testicular contractions. Oimethyl-4-phenylpiperazinium (OMPP), 
6 
a postjunctional stimulant of autonomic ganglia, induced a 
contraction, but this could be abolished by bretyliurn (an agent 
that prevents adrenergic transmitter release). On the other 
hand, the preparation was not affected by atropine or hexa-
methonium (Rikimaru and Suzuki, 1972). These data suggest that 
there is an adrenergic innervation of the rabbit tunica albuginea. 
Tetrodotoxin did not affect autorhythmic contractions but 
reduced the contractile response to electrical field stimulation. 
This response was abolished by I 111'1 Mn++ in the bathing medium 
(Rikimaru and Suzuki, 1972). One interpretation of these data 
would be that sodium is less important than calcium ion in 
producing these contractions, since tetrodotoxin blocks 
permeability of cells to sodium, and Mn++ can antagonize the 
effects of calcium ion. The lack of effect of bretylium, atropine 
or tetrodotoxin on spontaneous contractions also implicated 
substances other than catecholamines or acetylcho1ine in engendering 
autorhythmicity. More recent observations on the human capsule 
failed to detect either catecholamine-containing nerves or 
7 
acetyicholinesterase activity (Shirai et al., 1973), although 
rat capsules appeared to have both types of nerves (Bell and 
McLean, 1973). In addition, electrical field stimulation of the 
perivascular nerves of dogs produced a pressure rise equivalent 
to 50 rrm H20 within the testis (Rikimaru et al., 1972). 
Nonnervous factors have recently been implicated in the 
control of spontaneous rhythmicity of rabbit testicular capsules. 
Hargrove, Johnson and Ellis, 1971, and Johnson, Hargrove and 
Ellis, 1971, found that PGE1 and PGF10 , respectively, inhibited 
or stimulated rabbit testicular contraction. Later work showed 
that PGE1 and E2 stimulated inactive testes at low doses but 





the preparation at all doses (Hargrove et al, 1973; Seeley et al., 
1974). Compounds that had PG-like properties (Hargrove et al., 
1973), that co-chromatographed with authentic PGs, and possessed 
smooth muscle-stimulatory properties (Seeley, 1973), were released 
into the bathing medium in vitro and in vivo (Seeley et al., 1974). 
Changing the original bathing medium abolished spontaneous 
rhythmicity in vitro, while bathing the inactive preparation in 
the original media restored activity (Hargrove et al., 1973). 
These effects, however, could not be demonstrated in vivo 
(Seeley et al., 1974). In addition, both rat and rabbit testes 
yielded extractable, PG-liKe material when whole testes were 
homogenized (Seeley, 1973). PGs added to the bathing medium of 
rabbit testicular capsules not only induced contractions in most 
8 
quiescent preparations, but also potentiated the responses of the 
testes to exogenous epinephrine and histamine (Hargrove, Seeley 
and Ellis, 1973}. 
Investigation into the mechanism by which PGs stimulate 
rabbit testicular capsules showed that calcium ion (Ca++) stimulated 
active, but not inactive, preparations (Hargrove, Seeley and Ellis, 
1973). PGs could restore this Ca++ stimulation in a dose-
dependent manner and were themselves dependent on Ca++ for their 
action. Thus, a reciprocal dependency was observed between PGs 
and Ca++. Seeley et al., 1974, investigated the inhibitory 
action of PGEs and suggested that inhibition was due to the 
accumulation of cyclic adenosyl 3',5' monophosphate (cyclic AMP}. 
A tonus decrease or complete relaxation of the capsule could be 
produced by either dibutyryl cyclic AMP or theophylline, the 
latter being a compound that causes cyclic AMP to accumulate 
intracellularly by blocking cyclic nucleotide phosphodiesterase. 
In sunmary, low concentrations of PGEs apparently stimulate 
capsular contractility by allowing increased Ca++ into the cell, 
and higher doses inhibit testicular motility by causing cyclic AMP 
to build up. PGFs, however, have no apparent effect on cyclic AMP 
and do not inhibit the testis. 
Other studies on the testicular capsule showed that testosterone 
and other steroids inhibited contractility in vitro (Seeler et al., 
1972). However., these steroids had no effect in vivo (Seeley 
et al., 1973). Some mechanism apparently prevents steroid 
9 
inhibition of the capsule's activity in the live rabbit, a result 
of interest,since the testis is the site of testosterone 
production. 
Some results from other laboratories may suggest roles for 
testicular capsular contractions. Free and Jaffe, 1972, noted 
rhythmical pulsations of blood pressure in rat testes, possibly 
implicating the capsule as a regulator of hemodynamics. 
Concerning the tunica albuginea's speculative role in sperm 
transport, it has been shown in rabbits that injections of PGF2a 
and PGE2 can affect sperm numbers in the deferent duct (Hafs, 
Louis and Stellflug, 1974) and reduce sperm transport time by 
two days (Hunt and Nicholson, 1972). 
Testicular prostaglandin production, 
distribution and metabolism 
Early attempts failed to detect PGs in testes (Von Euler 
and HaITJTiarstrom, 1937; Horton and Thompson, 1964) or to show 
entry of tritiated PGE1 into rat or dog testes (Nakano, 1970). 
However, PGs E1, E2, and F2a were reported to be present 
endogenously and to be synthesized by rat testes injected 
with 14C-linoleic acid (Carpenter and Wiseman, 1970; Carpenter 
et al. 1971). Acidic lipids that co-chromatographed with 
authentic PGs E1, E2, Fla and F2a and possessed smooth muscle-
stimulatory properties were found to be released by rabbit testes 
into saline solution during pharmacological studies (Hargrove 
10 
et al., 1973; Seeley, 1973). Larger quantities of such PG-like 
material were extracted from rabbit and rat testes (Seeley, 1973) 
and from swine testes (Michael, 1973). Studies employing bio-
assay (Seeley, 1974), gas chromatography, or radioimmunoassay 
(Carpenter, 1974) to detect PGs all suggest that the major PG 
in rat testis is F2a. Carpenter (1974) pointed out that the 
principal PGs produced by a tissue often correspond to the amount 
of precursor polyenoic fatty acid present and that this generaliza-
tionholds for the testis, since arachidonic acid predominates 
there. Thus the quantities of PGF2a and E2 exceed those of Fla 
and E1 (Seeley, 1973; Carpenter, 1974). In addition, Carpenter 
extracted about five times as much PGF2a from immature, as 
compared to mature, organs. Rabbit testicular homogenates 
convert approximately one percent of substrate into PGE1 (Christ 
and Van Dorp, 1972); comparable studies have not been carried out 
for conversion of arachidonate into PGF2a or E2. 
PGB and material that may represent other PG metabolites 
also appear to be present in rat testes (Carpenter, 1974). PGs 
are rapidly metabolized by testicular homogenates of either rat 
or swine testes. Both 15-hydroxy-PG dehydrogenase and prostaglandin-
delta 13-reductase are present in the supernatant, particle-free 
fractions (Anggard, Larsson and Samuelsson, 1971; Nakano and 
Prancan, 1971; Nakano, Montague and Darrow, 1971). The 
dehydrogenase enzyme was more active in the testicular preparation 
than in the ovary, uterus or placenta, and the reductase enzyme 
11 
was comparable in activity to homogenates from such sources 
(Nakano, Montague and Darrow, 1971). In view of the suggested 
importance of PGs for ovarian and uterine function (labhsetwar, 
1974), the greater metabolic capacity of the testis for these 
compounds could indicate equivalent functional importance in 
the male gonad. There is increasing evidence that points to a 
dependence of testicular and seminal vesicular PG production on 
androgens and pituitary gonadotropins. Ellis and Baptista (1969) 
observed that testicular production of malonaldehyde (a by-product 
of PG synthesis and lipid peroxidation) decreased following 
hypophysectomy in rats. In addition, PG synthetase activity 
decreased significantly five weeks after hypophysectomy, and 
possibly after adrenalectomy as well (Ellis, Johnson and Hargrove, 
1972. In corroboration of pituitary control of PG synthesis, 
Sturde (1971a) found that a synthetic androgen, methyl andros-
tanolone, increased seminal PG concentration from 0.9 to 6.7 mg/ml 
in human males attending a fertility clinic. He also noted a 
doubling of sperm concentration from 8·.2 to 16.4 million/ml. 
later studies showed that treatment with human chorionic 
gonadotrophin (HCG) increased seminal prostaglandins without 
altering sperm numbers in 24 subjects (Sturde and Bohm, 1971). 
Paradoxically, administering an antiandrogen (Cyproterone; 200 
to 400 mg) for 4-16 weeks also increased seminal PGs, possibly 
due to in~reased gonadotrophin output following abolition of 
negative feedback by androgens (Sturde, 1971b). Homogenates of 
12 
seminal vesicles collected from rats one day after hypophysectomy 
have only 30 percent of the capacity for PG biosynthesis shown by 
controls. Hypophysectomy also inhibited the conversion of 
arachidonic acid to PGE2 in vitro and depleted rat seminal 
vesicles of their stores. of arachidonate (Tan and Privett, 1973). 
These investigators noted that hypophysectomy, like essential 
fatty acid deficiency, can produce dermal scaling despite dietary 
supplements of these fatty acids; moreover, essential fatty acid 
deficiency mimicks hypophysectomy in that it leads to testicular 
atrophy. In addition, mating increased the PG content of vasa 
deferentia from mice compared to tissue from isolated, nonexposed 
animals (Marley and Smith, 1974). Barcikowski, Saksena and 
Bartke (1973) administered testosterone propionate to castrated 
rats and found an increase of plasma PGF levels from 0.9 to 4.1 
ng/ml. A low dose of cyproterone acetate decreased plasma PGF, 
while a high dose increased it (in agreement with Sturde, 1971b). 
PGs also decrease testosterone output, a result similar 
to the luteolytic capacity of PGs in the female. Such an effect 
has been observed followjng injections of PGF2a, E2, A1 or A2 
(Bartke et al., 1973; Saksena, El Safoury and Bartke, 1974). 
The site of action probably is testicular, since prostaglandins 
induce the release of pituitary gonadotropins (Harms, Ojeda and 
Mccann, 1974}. The site of action for reduction of testosterone 
output may be cholesterol esterase, an enzyme that cleaves the 
testosterone precursor, cholesterol, from fatty acids that are 
bound to it. Bartke et a1. (1973) noted that 200 ug of PGF
2
a 
injected sc into mice lowered testosterone and increased the 
concentration of 'esterified cholesterol in the testis. Free 
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and Tillson (1973) suggested that the depressed testosterone 
secretion rate they measured following iv PGE2 infusion in rats 
may have been caused by the depressed testicular blood flow 
that they also observed. However, other work suggests a 
stimulatory effect of PGs on steroid synthesis. For instance, 
Eik-Nes (1971) noticed an increased testosterone outflow 
fo11owing high PGE2 infusion rate {1 ug/min). One rationalization 
for such an effect may be that PGEs can increase 3',5'-cyclic 
adenosine monophosphate (cyclic AMP) in minced rat testes 
(l mM caffeine was also present). according to Butcher and 
Baird (1968)~ No effect of PGE1 or Fla was observed for cyclic 
AMP accumulation in seminiferous tubules (Kuehl et al., 1970a, 
so the Leydig cells would be the presumed site of action. Kuehl 
and coworkers (1970b) noted that a proposed PG antagonist, 
7-oxa-13-prostynoic acid, blocked the rise of cyclic AMP induced 
by follice-stimulating hormone (FSH) in rat testes. This 
important observation may indicate a natural ro1e for PGs 
in mediating or contributing to testosterone production that 
follows gonadotropin stimulation. 
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MATERIALS AND METHODS 
Experimental animals 
Mature male rabbits of mixed breeding (Dutch Belted, New 
Zealand, or crosses of these strains) were either obtained from 
local sources or raised in a small animal laboratory. The 
rabbits were isolated from females, under natural photoperiod, 
and at a temperature range of 70 to 80 degrees Fahrenheit 
(approximately 21 to 27 degrees C) in a small animal laboratory. 
Rabbits were provided with water and feed (Purina rabbit chow) 
ad libitum. Data recorded from 63 rabbits are presented in this 
investigation. 
Exposure of male rabbits to females 
Eight male rabbits were transferred to large dog cages in 
which rabbit cages containing females had been placed. These 
buck rabbits were maintained with the females for two weeks 
prior to sacrifice. Conditions of temperature, photoperiod and 
feed were similar to those given in the preceding paragraph. 
Experiments in vitro 
Testes used for studies in vitro were obtained by anesthetizing 
the animals with sodium pentobarbital (20 to 60 mg per kg ip or iv; 
Abbott Laboratories), supplemented with ether when necessary. 
The experimental rabbits were restrained with their ventral sides 
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up on a small animal operating table. An incision was made 
through the scrotum and tunica vaginalis parietal, the blood 
supply was excluded with a ligature, and the testis was excised. 
Cotton ligatures were attached to the testicular capsule at both 
the superior and inferior poles. This preparation was then 
suspended in a water-jacketed muscle warmer that contained 
oxygenated Tyrode's solution at a temperature of 35 degrees C. 
The lower thread was secured to a rubber stopper, while the 
upper one passed to a sensitive myograph transducer (Statham Co.) 
attached to a recording Gilson minipolygraph (Figure IA). 
Experiments in vivo 
Once the testis used for in vitro studies had been removed 
from the rabbit, the incision in the scrotal sac was closed with 
wound clamps, and the opposite scrotum was similarly opened. 
Cotton threads were attached to the two poles of the testis and 
used to draw it through a celluloid dam into a second water-
jacketed muscle warmer that was not provided with oxygenation. 
A circular wire tie was passed around the base of the muscle 
warmer, thereby securing the scrotal sac, celluloid dam and 
inferior cotton thread to the base. This arrangement sealed 
the peritoneal cavity against leakage of Tyrode's solution from 
the muscle warmer. The rabbit's anterior end was then elevated, 
the preparation was checked for signs of ischemia, and the 
superior thread was finally attached to a myograph transducer as 
described above (Figure 1B). 
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Figure 1. Diagram showing the testicular preparation (a) in vitro 
and (b) in vivo. 
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Treatments 
Prostaglandins E1 and F2a (Upjohn Co.), testosterone 
proprionate (Sigma) and indomethacin (Merck, Sharpe and Dahme, 
Inc.) were dissolved in 95 percent ethanol and added directly to 
the bathing medium. Mixing the drug into the medium was 
accomplished by the oxygen bubbles for .i.!:!_ vitro studies, and 
manually for .ii!. vivo investigations. L-epinephrine, norepine-
phrine and acetylcholine (Sigma), L-propranolol (Ayerst 
Laboratories), and theophylline (K & K Laboratories, Inc.) were 
dissolved in distilled water and added to the bathing medium. 
The epinephrine stock solution was acidified with HCl in order 
to solubilize the epinephrine. 
Groups of four animals each were injected ip with the 
following agents: 2 ml corn oil (this served as the vehicle for 
all other agents), or 15 mg/kg indomethacin, 25 mg/kg of 
5,8,11,14-eicosatetraynoic acid (Hoffmann-La Roche, Inc.), 5 mg/kg 
reserpine (Sigma), or 15 mg/kg indomethacin plus 0.5 mg/kg PGE1. 
Each agent was injected ip in 2 ml of corn oil. Blood samples 
were taken prior to injection and at 1, 4 and 12 hours thereafter 
by cardiac puncture. The samples were centrifuged for 5 minutes 
in a clinical ·centrifuge, and the serum was pipetted for storage 
at -20 degrees C. These samples were analyzed for testosterone 
by radioimmunoassay (see below). The following day the rabbits 
were anesthetized and testicular contractions were measured in vivo. 
The contralateral gonad was frozen in a small volume of Tyrode's 
solution at -20 degrees C and later assayed for endogenous PGs. 
Pressure recording and electrical 
stimulation 
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Intratesticular pressure changes were recorded from eight 
rabbits. A 21-gauge needle was attached to a Statham pressure 
transducer (range: 0-15 mm Hg) that contained heparinized Tyrode's 
solution in the recording chamber. The needle was inserted into 
the testis directly through the scrotal sac. After half an hour 
of recording basal contractility, norepinephrine or isoproterenol 
(0.2 mg) was infused into the marginal ear vein. In six rabbits 
electrical stimulation of the perivascular nerve in the spermatic 
cord was also attempted. An incision 1 cm in length was made 
through the scrotum at the juncture of the vas deferens and 
epididymal fat pad. A pair of silver-silver chloride electrodes 
was touched to the vas and electrical current (0.5 to 4.0 volts, 
50 Hz, 20 ms duration and 20 ms delay) was passed through the 
tissue. Pressure changes were simultaneously recorded. A Grass 
stimulator served as a source for electrical current. 
Extraction and chromatography of 
prostaglandin-like compounds 
Argentaffin thin-layer chromatography was carried out, using 
plates prepared as described in Green and Samuelsson (1964) with 
a coating of silica gel (Merck type H, without gypsum binder). A 
slurry was prepared with the following proportions: 30 g of silica 
gel, 60 ml of water and 6 g silver nitrate. This slurry was 
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spread onto glass plates that had been washed in acidic methanol 
and rinsed with deionized distilled water. The gel formed a 
layer approximately 0.25 mm thick. These plates were activated 
by heating for 30 minutes at 110-115 degrees C, and were there-
after stored in a dessicator in a darkened cabinet. Residues 
from acetone-extracted testicular homogenates were applied to 
these plates in 50 µl of ethanol. The plates were developed in 
the A-II solvent system of Green and Samuelsson (1964), comprised 
of ethyl acetate, acetic acid, methanol, 2,2,4-trimethylpentane 
and water in the ratio of 110:30:35:10:100 v/v. The resulting 
mixture was equilibrated for two hours and the less-polar phase 
was used to develop the plates. 
Rabbit testes were extracted as follows: Testes were 
decapsulated by opening the tunic with a razor blade, holding the 
capsule tightly with forceps, and scraping the contents out with 
the razor blade. The tubules were weighed and homogenized in a 
heavy glass tube, using a drill with a Teflon pestle attachment, 
and 20-ml aliquots of acetone. The homogenate was centrifuged 
at 10,000 rpm for five minutes and the supernatant was transferred 
to an evaporation flask. After two further washes and centrifu-
gations of the residue, the acetone extracts were evaporated under 
negative pressure in a rotary evaporator at a temperature of 
40 degrees C. The resulting residue was taken up in 20 ml of 
acidic phosphate buffer (pH, 3.0) and subsequently partitioned 
three times against equal volumes of ethyl acetate. After the 
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organic solvent was evaporated, the residue was chromatographed 
as described above. 
Once the chromatograms were developed, zones that migrated 
with authentic PGE2, E2, Fla or F2a were scraped from the plates 
and eluted three times with 5-ml volumes of methanol. The 
resulting extract was dried under nitrogen gas at 40 degrees C, 
taken up in 5 ml of phosphate buffer (pH, 3.0), and partitioned 
three times against ethyl acetate. The ethyl acetate was 
evaporated under nitrogen gas to yield a residue carrying 
prostaglandin-like compound. This residue was dissolved in 20 ml 
of prewarmed Tyrode's solution and bioassayed on the rabbit 
testicular capsule. 
Testosterone radioimmunoassay 
Sequential blood samples were taken by cardiac puncture just 
prior to and at 1-, 4- and 12-hour intervals after injection with 
indomethacin (15 mg/kg), PGE1 (0.5 mg/kg), indomethacin plus 
PGE1 (same doses), 5,8,11,14-eicosatetraynoic acid (25 mg/kg) or 
reserpine (5 mg/kg). The unanaesthized rabbits were restrained 
by an assistant while about 1-2 ml of blood was drawn from the 
heart into a 5-ml syringe equipped with a 21-gauge disposable 
needle. The blood was centrifuged for 10 minutes before the serum 
was pipetted off and transferred to vials for storage at -20 degrees 
C. 
Radioimmunoassay for plasma testosterone levels was carried 
out according to the procedure of Mongkonpunya and Niswender, 1973. 
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Duplicate aliquots of serum or plasma (0.1 ml) were placed 
in disposable culture tubes (15 x 80 mm). To account for 
procedural losses, 2000 dpm of 3H-1,2-testosterone (New England 
Nuclear; 45 c/mM, repurified by column chromatography) was added 
to a third aliquot from a representative number (10 to 20 within 
each assay) of unknowns. Samples of serum with 3H-1,2-testosterone 
were vortexed for 10 sec and endogenous and labelled hormones 
were allowed to equilibrate for 30 min. Serum was extracted by 
vortexing with 2.0 ml of nanograde diethyl ether:hexane (1:2) 
for 30 sec. Tubes were then stored at -20 degrees C for at least 
1 hr to freeze the aqueous phase. With precautions taken to avoid 
thawing the aqueous phase, extracts destined for radioimmunoassay 
were decanted into disposable culture tubes (12 x 75 mm) and 
those for procedural losses were decanted into scintillation vials. 
Radioactivity of these extracts was averaged to determine a single 
correction factor to account for procedural losses of testosterone 
in all serum samples. 
Standard testosterone (Sigma Chemical Co.) was pipetted from 
a stock solution of 10 ng/ml and at least two sets (0.0, 0.025, 
0.05, 0.1, 0.25, 0.50, 1.00 and 1.50 ng) were included in each 
assay. Standard testosterone and serum extracts were dried 
under nitrogen. Tube walls were rinsed once with minimal amounts 
of analytical grade diethyl ether and dried under nitrogen. 
Gelatin (0.1 percent, Knox Gelatin), in 0.01 M phosphate-
buffered saline, was used to dilute the antibody to 1:3000. 
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Antibody (0.2 ml) was added to each tube, vortexed for 10 sec 
and allowed to incubate at room temperature for 30 min. Two 
hundred microliters of 0.1 percent gelatin (Knox Gelatin, Inc., 
Johnstown, N. Y.) in 0.01 M phosphate-buffered saline, containing 
30,000 dpm of 3H-1,2,6,7-testosterone (New England Nuclear; 
91 c/mM), was added to each tube. The contents of the tubes were 
mixed for 5 sec and incubated for 12 to 18 hr at 5 C. 
To separate bound and free testosterone, 1.0 ml of 0.025 
percent dextran 150 (Pharmacia, Uppsula, Sweden) and 0.25 percent 
carbon decolorizing neutral norit (Fisher Scientific Co.) in 
glass distilled water was added to each tube. Contents were 
mixed, incubated in an ice bath for 10 min and then centrifuged 
at 2,500 g for 10 min at 5 C. A 0.5 ml-aliquot of the supernatant 
fluid was diluted with a liquid scintillation fluid (Bray, 1960) 
for quantification of radioactivity in a liquid scintillation 
spectrometer (Nuclear Chicago Corp., Mark I). 
For comparison among assays, standard sera with high and low 
testosterone, and extracts from blank extraction tubes, were 
assayed with each set of unknown serum samples. 
Estimations of serum unknowns from both bulls and rabbits 
determined by this method do not differ significantly from 
estimations performed on the same samples purified on Sephadex 
LH-20 columns (r = 0.985 and 0.932, respectively). Neither do 
values obtained by this method differ from determinations made on 
the same bull samples by gas liquid chromatography (r = 0.812) 
and competitive protein binding (r = 0.957). 
RESULTS 
Interactions of PGE1 with acetylcholine, 
PGF2a and epinephrine 
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Testicular contractions~ vivo were typically rhythmic 
(Figure 2). Acetylcholine stimulated capsular tonus (Figure 2A) 
with a threshold of about 2 x 10-8M. In the presence of 10-8M 
PGE1, however, the capsular tonus increased to a greater extent 
while amplitude of contraction decreased (Figure 2B). Higher 
concentrations of PGE1 (10-
7M) reduced or abolished spontaneous 
motility and stimulation due to acetylcholine (Figures 2C and 
4B). Two of the five preparations~ vivo failed to respond to 
acetylcholine in the absence of PGE1 while the others contracted 
markedly. This type of variability was not seen in response to 
epinephrine. 
PGE1 at 10-
7M final concentration also abolished the response 
to high doses of PGF2a jJ!. vivo (Figure 20). It prevented PGF2a-
induced stimulation of the testicular capsule jJ!. vitro in a non-
competitive manner at concentrations of PGE1 greater than 
7 x 10-8M (Figure 3). 
Figure 3C depicts the control LOR curve for epinephrine 
~ vitro; the LOR curve for norepinephrine was also determined 
but did not differ significantly from that for epinephrine (data 
not shown). The presence of 1.4 x 10-8 or 1.4 x 10-9M PGE1 
(Figures 5A and B, respectively) markedly potentiated the 
Figure 2. 
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Figure 3. A. LOR curve for PGF2 -induced increases in tonus of the testicular capsule in vitro. a -
B. PGF2a LOR curve in the presence of 7 x 10-
8M PGE1. C. PGF2a LOR curve in the 
presence of 1.1 x l0- 7M PGE1. 0. Abolition of testicular response in vitro to PGF2a 
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Figure 4. A. LOR curve for acetylcholine stimulation of testicular 
tonus in vivo. B. Acetylcholine's 
presence of 7 x lO-7M PGE1 ~ vivo. 
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Figure 5. A. LO~ curve for epinephrine-induced increases 
in tonus in vitro in the presen.ce of 1.4 x 10-9M 
PGE1. B. Epinephrine LOR curve in the presence -8 of 1.4 x 10 M PGE1. C. Epinephrine LDR curve 
with no PGE1 in medium. 0. Inhibitory effect 
of 1.4 x 10-7M PGE1 on epinephrine LOR curve. 
E. Effect of 7 x 10-?M PGE1 on epinephrine LOR 
curve. 




epinephrine-induced tonus increase of ..i!!_ vitro testicular capsules. 
Higher concentrations of PGE1, however, noncompetitively inhibited 
epinephrine-induced tonus increases at all concentrations tested 
and increased the threshold for stimulation (Figures 50 and E). 
At 7 x 10-7 PGE1, the maximum average stimulation by epinephrine 
was reduced to less than 30 percent of the control value. However, 
PGF2a (10-
7 to 10-6M) did not reduce epinephrine stimulation 
(data not shown). 
-8 PGE1 at 1.4 x 10 M potentiated the response of the capsule 
..i!!_ vivo to epinephrine as well (Figure 6A). As with the in vitro 
preparation, higher concentrations of PGE1 inhibited the testis 
and increased the amount of epinephrine required to stimulate 
( -7 the capsule Figures 6C and D). At 7 x 10 M, PGE1 reduced the 
average maximum tonus increase induced by epinephrine to about 
20 percent of the control value; in the presence of this 
concentration of PGE1, two of the five preparations studied gave 
no response to epinephrine. 
Epinephrine 1 s efficacy in stimulating the capsule ..i!!_ vitro 
exceeded that of either PGE1 or acetylcholine. Higher concentrations 
of PGE1 became progressively less stimulatory on isolated, rinsed 
preparations, while acetylcholine alone had no effect on such 
units in contrast to its stimulation of the testis in vivo 
(Figure 7C). 
According to the LOR curve for epinephrine ..i!!_ vitro 
(Figure 5C), higher doses became slightly less stimulatory. 

Figure 6. A. Potentiation of the in vivo testicular tonus 
increase to epinephrine by Llx l0- 8M PGE1. 
B. Epinephrine LOR curve i!!_ vivo in the absence 
of PGE1. C. and D. Inhibitory effects of 
1.4 x 10-7 and 7 x 10-7M PGE1 on the epinephrine 
LOR curve in vivo. ---
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Figure 7. A. Epinephrine LOR curve for the l!l vitro testicular 
capsule. B. PGE1 LOR curve l!l vitro expressed as percent 
of the maximum response to epinephrine. C. Acetylcholine 
LOR curve in vitro based on the maximum responses to 
epinephrine. 
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Theophylline (0.1 mM), a phosphodiesterase inhibitor, reduced 
epinephrine stimulation to 60 percent of the control value 
(compare Figures 88 and C). However, the beta-adrenergic-blocking 
agent, propranolol, not only restored, but also increased, the 
response of the capsule to a given dose of epinephrine in the 
presence of theophylline (Figure 8A). 
Effects of prostaglandin inhibitors 
and reserpine on testicular contractility 
The testicular contractions of 20 rabbits were measured 
j_n vivo for two hours after the preparations were set up. During 
this time, the Tyrode's solution was changed twice. Initial 
contractile force equaled a pen deflection of 0.324 g. After 
the first change of medium, the force was 0.322 g, and it was 
equivalent to 0.329 g after the second change. Neither of these 
latter values represented a statistical change in force (p > 0.50 
in both cases, according to a t-test). 
Injecting rabbits with indomethacin (15 mg/kg) twice prior 
to measuring ..i.!l vivo testicular contractility resulted in an 
average decrease in the initial amplitude of contraction, even 
though mean testicular weights for this group were greater than 
in the control group (see Table 1). Contractions were not 
abolished in nine of the 11 animals used, but were in two. In 
these two rabbits, the testes set up initial contractions that 
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Figure 8. A. Partial epinephrine LOR curve in the presence of 0.1 mM 
theophylline and l .2 ~M propranolol. B. Partial 
epinephrine LOR curve with no other treatment. C. Inhibition 
of epinephrine LOR curve in the presence of theophylline 
(O.l mM final concentration). 
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for the original (Figure 9A). This low level of contractility 
could be increased by administering PGF2a at a concentration of 
7 x l0- 8M into the Tyrode's solution (Figure 9B). In addition, 
three of the 11 animals pretreated with indomethacin had scrotal 
sacs filled with serous fluid, a condition known as hydrocoel. 
Injecting male rabbits with 5,8,11,14-eicosatetraynoic acid 
(an acetylenic inhibitor of prostaglandin synthesis) at 24 and 
one hour prior to the experiment, did not statistically reduce 
the amplitude of contraction (see Table 1). In only one of the 
six animals tested was there an obvious effect--a dramatic 
reduction in frequency of contraction (Figure 9C). 
To ascertain whether the reduction in amplitude of testicular 
contraction after indomethacin treatment was a direct or indirect 
effect, a solution of indomethacin in ethanol (10 mg/m) was made 
up. Aliquots of this solution were added to the bathing media of 
preparations~ vivo and~ vitro. Indomethacin at a final 
concentration of 7 x l0- 5M inhibited spontaneous contractions 
~ vitro (Figure lOA) and also reduced the tonus increase caused 
by 7 x l0- 8M PGF2a (Figure 10B). No such effect of indomethacin 
was noted~ vivo, however. Even at concentrations of 1.4 x l0- 4M 
of indomethacin, only a slight reduction of amplitude was observed 
j_Q_ vivo (Figure lOC). 
Catecholamines affect the testicular contractions pronouncedly. 
When one mg of epinephrine was injected iv through the marginal 
ear vein, testicular tonus increased to the point that contractions 
were temporarily effaced (Figure llA). Although catecholamines of 
Table 1. Effect of treatments on the amplitude of testicular contractions .i!:!_ vivo (means 
compared statistically with at-test).* 
1. None 
2. Indomethacin 
(15 mg/kg ip 




acid (25 mg/kg 




( 5 mg/kg ip 









Mean amplitude of 
contraction (cm) 
1. 62 ± 0.157 
0.98 ± 0. 195 
1. 36 ± 0. 370 
1.675±0.382 
*Values given as means± standard error of the mean. None 






of the means for 
Mean weight of 
testes ( g) 
2.192 ± 0.130 
2.459 ± 0.138 
1. 93 ± 0.126 




Figure 9. A. Abolition of testicular contractility in vivo one hour after injection with 
indomethacin {15 mg/kg ip). B. Stimulation of testicular contractions in an 
indomethacin-pretreated (15 mg/kg) rabbit .:f..!! vivo by prostaglandin F
20 
(7 x l0- 8M) 
C. Decreased testicular contractility .:f..!! vivo one hour after injection with 
5,8,11,14-eicosatetraynoic acid (25 mg/kg ip). 
A 
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neural origin are potential regulators of testicular contractility, 
injecting the rabbits with reserpine (5 mg/kg) at 18 hours prior 
to the experiment did not reduce the amplitude of contraction 
(Table 1). In addition, dibenamine (an agent that blocks 
catecholamine receptors) at concentrations of 9.6 x 10-6M did not 
reduce contractility even in reserpine-pretreated animals 
(Figure 11B). Dibenamine was potent in abolishing catecholamine 
stimulation of inactive testes i.!!_ vitro, however (Figure llC). 
Another potential regular of testicular motility is 
acetylcholine. This compound stimulates the tonus of testes 
i.!!_ vivo and increases frequency of contraction (Figure 11D). 
Adding atropine (a blocker of acetylcholine receptors) to the 
medium i!:!_ vivo did not reduce contractility at low doses; at 
concentrations greater than 10-4M, it stimulated testicular tonus 
increases (Figure llE). Variability of total PG content of testes 
from each treatment group (i.e., control, indomethacin, 
tetraynoic acid or reserpine) was so large that no statistical 
differences were observable among groups (Table 2). 
Electrical stimulation and intratesticular 
pressure recordings 
Small rhythmical fluctuations in pressure occurred in the 
intact testis (Figure 12A). Neither an increase nor a decrease 
in pressure followed electrical stimulation of the perivascular 
nerve and spermatic cord (Figure 12B). Pressure changes did 

Figure 10. A. Decreased rate of spontaneous testicular contractions in vitro after 
addition of indomethacin (7 x l0- 5M) to the bathing medium-. B. Inhibition 
of prostaglandin F2 - induced tonus increase of rabbit testis in vitro a -
by indomethacin (7 x l0- 5M). C. Lack of effect of indomethacin 












Figure 11. A. Testicular tonus increases recorded in vivo following two injections of epinephrine 
(1 mg) into the marginal ear vein. B. Lack of inhibitory effect of dibenamine 
(9.6 x 10-6 M) in vivo on testicular contractions of a rabbit pretreated with 
reserpine (5 mg/k~). C. Inhibitory effect of dibenamine (4.8 x 10-6 M) on tonus 
increase and contractility induced in vitro. D. Stimulation of testicular 
contractility in vivo by acetylcholine (1.35 x 10-6M). E. Stimulation of testicular 
contractility in vivo by atropine (2.1 x ,o-4M). 

Table 2. Bioassay data showing average prostaglandin F?a equivalents (µg per g of testis weight) 
recovered by extraction and chromatography procedure.* 
PGE1 PGE2 PGFla 
Control 
(n = 4) 0.834 ± 0.458 0.564 ± 0.299 0. 21 ± 0. 15 
Indomethacin 
( n = 5) l. 162 ± 0.692 l. 33 ± 0.49 0.683 ± 0.353 
Reserpine 
(n = 4) l. 51 ± 0.657 l. 493 ± 0.937 0.393 ± 0. 148 
Tetraynoic acid 
(n = 4) 0.43 ± 0. 15 0.278 ± 0.098 0.29 ± 0. 135 
*No value was significantly different from the controls at a level of 0.05. 
means± standard error of the mean. 
PGF2a 
0.058 ± 0.018 
0.826 ± 0.894 
2.28 ± 2.07 
0.078 ± 0.039 




follow iv unfusion of pharmacological agents, however. Both 
norepinephrine and PGF2a increased intratesticular pressure, 
whereas isoproterenol and PGE1 decreased it (Figure 12C-F). The 
inhibition of pressure fluctuations that took place after iv 
infusion of 0.2 mg isoproterenol lasted for a minimum of 30 
minutes. During this time norepinephrine failed to increase 
intratesticular pressure (data not shown). 
Miscellaneous pharmacological effects 
To ascertain whether any interaction occurred between PGs 
and alpha-adrenergic-blocking agents, dibenamine (1.9 x 10-6M) 
was added to testicular preparations .i!!_ vitro after they had been 
stimulated to contract by PGF2a. Dibenamine did not reduce 
PG-induced tonus increases or amplitude of contraction (Figure 13A). 
The effect of a PG precursor, arachidonic acid, on spontaneous 
contractions .i!!_ vitro was found to be inhibition (Figure 13B). 
The inhibitor of PG synthesis, aspirin, had no obvious effect 
on testicular contractions in vitro at concentrations 4 x 10-5M 
(Figure 13C). Prostaglandin A2, like PGFs, was stimulatory 
in vitro at all concentrations tested (Figure 14). 
Adenosine (0.1 mM) inhibited tonus increases caused by PGE1 
(Figure 15A). At a ten-fold higher concentration, adenosine 
abolished testicular contractility that had been brought about 
by PGE1 (data not shown). Caffeine, a cyclic nucleotide-phospho-
diesterase inhibitor, also reduced tonus and frequency of 
testicular contractions (Figure 15B). Cyclic 3' ,5'-guanosine 

Figure 12. A. Pressure fluctuation recorded from rabbit testis i!!. vivo. 8. Intratesticular 
pressure during electrical stimulation (1.0 V, 50 Hz, 20 ms duration) 
of spermatic cord. C. Intratesticular pressure fluctuation inhibited by iv 
isoproterenol infusion (0.2 mg). D. Intratesticular pressure increase following 
iv norepinephrine infusion (0.2 mg). E. Intratesticular pressure following iv 
PGF
20 
infusion (0.2 mg). F. Intratesticular pressure following iv PGE1 infusion 
(0.2 mg). 
• • 
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Figure 13. A. Lack of a dibenamine-induced inhibition of testicular tonus increase on 
contractility in vitro caused by prostaglandin F2 (7 x 10-
7M). 
--- a 
B. Inhibitory effect of arachidonic acid (1.65 x 10-4M) on spontaneous 
testicular contractions in vitro. C. Lack of effect of aspirin 
(4.2 x 10-5M) on spontaneous contractions in vitro. 











Figure 14. LOR curve for prostaglandin A2 stimulation of testicular 
tonus in vitro. 

Figure 15. A. Stimulation of testicular tonus ~ vitro by prostaglandin E1 (7.2 x 10-
8M) followed 
by inhibition after addition of adenosine (10-4M). B. Stimulation of tonus in vitro 
by prostaglandin E1 (7.2 x l0-
9M) with subsequent· inhibition by caffeine (3.5--; l0- 5M). 
C. lack of effect of cyclic GMP (10-4M) on spontaneous testicular contractions 
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monophosphate slightly inhibited spontaneous testicular 
contractions~ vitro at a concentration of 0.1 mM (Figure 15C). 
This cyclic nucleotide also inhibited contractions in vivo, 
particularly at 1 mM concentrations (Figure 15D). 
Testosterone progressively inhibited testicular tonus 
increases in vitro that were caused by PGF
20 
{Figure 16A-C). 
Increasing the concentration of PGF
20 
did not overcome this 
inhibition. 
Testosterone radioimmunoassay 
Taking sequential blood samples by cardiac puncture resulted 
in a decreased plasma testosterone level in several animals 
(Table 3). This decrease obscured any differences that may have 
been due to treatment. In addition, temporarily high levels of 
testosterone in a few individuals caused total variability to be 
very large, further confounding the measurement of plasma 
testosterone. 
Exposure of male rabbits to females 
Testes of 11 male rabbits that had been exposed to females 
for two weeks contracted autorhythmically in vivo and in vitro. 
The mean amplitude of testicular contraction in vitro was 0.155 ± 
0.059 g. No statistical difference was found between this value 
and the amplitude of contraction of 12 testes in vitro from 
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Table 3. Serum testosterone levels (ng/ml) obtained from male rabbits injected with indomethacin, 
tetraynoic acid, reserpine, prostaglandin E1, or prostaglandin E1 plus indomethacin. Values are given as means± standard error Of the mean. 
Time, post-injection (hours) 
0 4 12 
Control (n = 6) 4. 51 ± 1. 83 2. 41 ± 0.43 l. 48 ± 0.68* 2. 71 ± 0.86 
Indomethacin ( n = 5) 1. 81 ± 0.50 1. 01 ± 0.83 5.28 ± 4.59 1. 15 ± 0.29 
Tetraynoic acid ( n = 5) 12.70 ± 5.20 2.84 ± 1.09 5.49 ± 3.67 2.40 ± 1. 27 
PGE1 ( n = 4) 8.08 ± 2.82 3.27 ± 0.94 1.07 ± 0. 14* 4.84 ± 2.09 
PGE1 + Indomethacin (n = 5) 4.95 ± 1. 19 3.75 ± 1. 30 8.27 ± 5.27 9.44 ± 2.84 
Reserpine (n = 4) 7.25 ± 2.75 4.28 ± 2.01 l . 14 ± 0.62 0.87 ± 0.10 
*Asterisk indicates significant difference from the initial value (0 hours after injection) at 




range of contractile amplitude ran from Oto 1.0 g. Testicular 
weights were 2.104 ± 0.167 g for the exposed males and 2.267 ± 
0.133 g for the isolated animals. 
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DISCUSS ION 
The general potentiating effect of PGs at very low concen-
trations on contractions of smooth muscle induced by agents such 
as epinephrine, acetylcholine, and calcium was noticed by Clegg, 
Hall and Pickles (1966) and Eagling, Lovell and Pickles (1971). 
This phenomenon was attributed to increased calcium entry into 
the cell (Clegg, Hall and Pickles, 1966). Indeed, not only do 
PGs depend on calcium for their stimulation of the rabbit 
testicular capsule, but a reciprocal dependency exists, since 
high calcium concentrations (4-12 mM) have no effect on capsular 
tonus in vitro unless a stimulating agent such as a PG, epinephrine 
or histamine is present {Hargrove, Seeley and Ellis, 1973). Our 
results demonstrate that PGE1 at low concentrations potentiates 
testicular capsular contractions induced by other agonists 
in vivo and in vitro. Since PGs are synthesized in rat and rabbit 
testes (Carpenter, Manning and Wiseman, 1971; Ellis, Johnson and 
Hargrove, 1972; Carpenter, 1974), such potentiation may occur 
naturally. 
The bimodal effect of PGE1, which leads to inhibition at 
higher doses, correlates well with the observation of Clegg (1966), 
who showed that low concentrations of PGE1 potentiate, while high 
doses inhibit, the response of guinea pig seminal vesicles to 
catecholamines. In addition, it agrees with the bronchiodilator 
and vasodilator properties of PGEs (Smith, 1973) that are not 
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observed with PGFs. Andersson et al. (1973) recently demonstrated 
that the relaxing effect of PGE2 on the sphincter of Oddi coincided 
with a 50 percent increase in tissue cyclic AMP content. However, 
the gall bladder contracted in response to PGE2 and showed a 
decrease in cyclic AMP. Increased cyclic AMP correlates with an 
inhibition of smooth muscle motility in several organs (Triner 
et al., 1971). PGE1 does stimulate testicular cyclic AMP 
formation (Kuehl et al., 1972). These facts suggest that the 
bimodal action of PGE1 in altering testicular capsular responses 
to epinephrine and acetylcholine may be due to increased calcium 
loading at low concentrations, followed by cyclic AMP accumulation 
at higher concentrations. 
Propranolol, a beta-adrenergic-blocking agent, markedly 
increased the response of the testicular capsule to high doses of 
epinephrine, while theophylline (a phosphodiesterase inhibitor) 
reduced the capsular response. Rikimaru and Suzuki, 1972, showed 
that both alpha- and beta-adrenergic receptors exist in the 
capsule, and that epinephrine becomes inhibitory in the presence 
of alpha-adrenergic-blocking agents. The inhibitory action of 
theophylline in rabbit aorta and epinephrine in rat uteri 
coincides with a rise in smooth muscle cyclic AMP and can be 
duplicated by exogenously-added dibutyryl cyclic AMP (Triner et 
al., 1971). The increased testicular capsular stimulation by 
epinephrine seen in the presence of the beta blocker, propranolol, 
may therefore be due to a decrease in cyclic AMP. The beta-
adrenergic agonist, isoproterenol, inhibits the testicular capsule 
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in vitro and i!!_ vivo (Davis and Langford, 1970; Seeley et al., 
1973). 
All the agents tested (except acetylcholine) gave similar 
responses i!!_ vitro and i!!_ vivo. Acetylcholine will cause 
capsular tonus increases i!!_ vitro if the preparation is sponta-
neously contracting (Davis and Langford, 1970). Substances 
released by the testis into the bathing medium initiate 
contractions and appear to be necessary for the response to 
acetylcholine i!!. vitro. We have previously shown that several 
f 
prostaglandin-like compounds are responsible for much of this 
spontaneous activity (Hargrove et al., 1973). It is therefore 
plausible that presence of these compounds, as well as nerve 
activity, could account for the observed difference between the 
testicular capsular response to acetylcholine i!!_ vitro and i!!. vivo. 
The fact that PGE1 suppresses increases in tonus and 
contractility brought about by PGF2a and other agonists demonstrates 
that this inhibition is a general phenomenon in the testicular 
capsule. At least one PG-induced effect can be totally blocked 
by a second type of prostaglandin, a result of special interest, 
since PGs of both the E and F type are generally produced together 
in tissues (Carpenter, Manning and Wiseman, 1971; Sih and Takeguchi, 
1973), although interactions between them have rarely been 
considered. In this regard, rat and rabbit testes normally produce 
more PGF2a than PGE2. Known mechanisms could shift this balance 
or increase the total PG content. For instance, epinephrine, 
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norepinephrine or serotonin can activate PG synthetase and furnish 
reducing equivalents that increase F-type PGs at the expense of 
E-type (Sih and Takeguchi, 1973); divalent metal ions such as 
++ Cu can have the same effect (Maddox, 1973). Either physiological 
or pathological changes of function could thereby modify 
testicular capsular motility, possibly resulting in altered sperm 
transport or testicular hemodynamics. 
Testicular capsules from some sources, but not all, do 
receive autonomic innervation. The canine testis responds to 
stimulation of the perivascular nerve with a rise in intratesticular 
pressure equivalent to 50 mm of water (Rikimaru et al., 1972). 
Other capsules--such as those of the bull (Shioda and Nishida, 1966), 
the rat (Bell and McLean, 1972), the rhesus monkey and man 
(H. G. Baumgarten, personal communication to Norma Hodson, 1970)--
contain nerve fibers that may go to the vascular system, but any 
connection with the smooth muscle of the tunica albuginea has not 
been demonstrated. Although Cross (1959) noted increased contract-
ility of rabbit testes j_Q_ vivo after stimulating the sympathetic 
centers of the hypothalamus, this effect may have been mediated 
by adrenal catecholamine release (Cross and Silver, 1962). In the 
human testis, only vascular nerves were found (Baumgarten et al., 
1968), a report that was confirmed by Shirai, Suzuki arid Rikimaru, 
(1973). Some contradiction exists between this latter report and 
an earlier pharmacological investigation that suggested the 
presence of such nerves. In this regard, Rikimaru and Shirai 
(1972) found that bretylium and tetrodotoxin interfered with the 
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response of testicular muscle to field stimulation (50 Hz, 
3V/cm); bretylium interferes with norepinephrine release from 
sympathetic nerves. 
Rikimaru and Suzuki (1972) also found that bretylium (but 
not hexamethonium or atropine) reduced contractions of rabbit 
testes that were elicited by field stimulation. The ganglionic 
stimulant, dimethylpiperazinium, also contracted the preparation; 
this contraction was reduced by bretylium, but recovered after 
washing the bretylium out of the bath and adding tyramine, a 
sympathomimetic agent. Though these results suggest the presence 
of sympathetic nerves, neither atropine nor bretylium reduced 
spontaneous contractions 1.!!_ vitro according to these investigators. 
The findings that neither atropine, dibenamine nor reserpine 
altered testicular contractions i!:!_ vivo (Figure llE; Table 1), plus 
the absence of tonus increases in the rabbit testis in vivo after 
electrical stimulation, cause one to conclude that nerves are 
not important factors in regulation of these contractions. 
Other alternatives include locally-produced, smooth muscle-
active compounds such as PGs, genuine autorhythmicity caused by 
electrogenic pumps, or sensitive response to adrenal catecholamines. 
This latter possibility is not likely, since dibenamine did not 
affect the contractions 1.!!_ vivo (Figure 11B). PGs, however, are 
produced by the testis (Ellis, 1972; Carpenter, 1974) and are 
released by the rabbit testis into the medium in vitro to initiate 
motility (Hargrove et al., 1973). The less labile contractions 
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j_Q_ vivo are responsive to PGs, but only small amounts are actually 
released into the bathing fluid (Seeley et al., 1974). It is of 
interest, then, that injecting rabbits with the PG synthetase 
inhibitor, indomethacin, significantly reduced testicular con-
tractions (Figure 9; Table 1). Although another PG synthetase 
inhibitor, 5,8,11,14-eicosatetraynoic acid, was without this 
effect, Willis, Davison and Rarrwell (1974) point out that this 
compound does not distribute readily in the body fluids, and 
therefore is often without effect on PG synthesis. Indomethacin 
added to the bathing medium had no direct effect j_Q_ vivo 
(Figure lOC), although it did inhibit tonus and contractility 
both of spontaneous origin and caused by PGF2a (Figures lOA and B). 
In addition, PGF2a restored contractility in testes from 
indomethacin-pretreated animals (Figure 9B). The lack of a direct 
effect j_Q_ vivo may indicate that indomethacin inhibits by 
preventing PG biosynthesis, rather than via its immediate action 
as a phosphodiesterase inhibitor that would cause cyclic AMP 
accumulation. Such an effect of this compound on phosphodiesterase 
has been demonstrated in bovine heart muscle by Stefanovich (1974). 
Due to the large variability of the PG estimates following extraction, 
thin-layer chromatography and bioassay, an effect of indomethacin 
on testicular PGs could not be confirmed (Table 2). At present, 
it seems that rabbit testicular contractions j_Q_ vivo are either due 
to prostaglandin production, or to spontaneous muscular processes, 
involving neither neurogenic factors nor prostaglandins. The 
information available, however, is more suggestive than conclusive. 
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The inhibitory action of PGE1 on testicular contractions 
appears to be due to the accumulation of adenosine 31 ,5 1 -mono-
phosphate (cyclic AMP). Beta-adrenergic agonists, such as 
isoproterenol, also inhibit capsular contractions; this effect 
is abolished by beta-adrenergic-blocking agents such as propranolol 
(Seeley, 1973; Seeley et al., 1974). Agents that cause accumulation 
of cyclic AMP by blocking the hydrolytic enzyme, cyclic nucleotide 
phosphodiesterase, inhibit contractions. Theophylline causes 
inhibition in this manner both in vitro and i!:!_ vivo (Seeley et al., 
1974), and caffeine has similar effects i!:!_ vitro (Figure 15B). 
Both cyclic AMP and its dibutyryl derivative decrease tonus and 
augment the inhibitory effect of PGE1 (Seeley et al., 1974). In 
the present study, inhibitory effects were also noted in response 
to both adenosine and guanosine 3'5'-monophosphate (cyclic GMP), 
as depicted in Figure 15A, C and D. An inhibitory activity may 
therefore be a general property of nucleotides and cyclic nucleo-
tides when added to testicular preparations at pharmacological 
doses. Lower levels of cyclic GMP within the cell may not affect 
muscle in the same way, since Kuehl et al. (1974) found increased 
cyclic GMP in rat uteri after estradiol treatment; these investigators 
noted that estradiol enhances uterine contractility. On the 
other hand, Mitznegg, Hach and Heim (1971) failed to observe any 
change in uterine responsiveness to oxytocin in the presence of 
-3 . 10 M cyclic GMP. 
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Arachidonic acid, a PG precursor, inhibited spontaneous 
testicular activity in vitro at concentrations of IO-3M (Figure 
13B). Whether this effect was related to increases in cyclic 
AMP was not investigated. PGA2 increased testicular activity 
and tonus at all concentrations, in this respect paralleling 
PGF1a and F2a (Johnson, Hargrove and Ellis, 1971; Seeley et al., 
1974). 
Testosterone inhibits spontaneous testicular contractions 
i!!_ vitro but not in vivo, and similarly depresses PGF2a-induced 
tonus increases and contractility (Seeley et al., 1972 and 1973). 
In the present study, this inhibitory effect of the androgen on 
testicular activity caused by PGF2a was found to be noncompetitive, 
in that high concentrations of PGF2a would not overcome the 
inhibition by testosterone (Figure 16). Any other relationships 
between steroids and PGs could not be ascertained, since the 
radioimmunoassay data were confounded by the stress of cardiac 
puncture (Table 3). In addition, human chorionic gonadotropin 
produced neither inhibition nor stimulation of testicular 
contractility (Seeley, 1973), even though it increases plasma 
testosterone in rabbits (Saginor and Horton, 1968) and seminal 
PGs in men (Sturde and Bohm, 1971). Finally, exposing male 
rabbits to females for two weeks did not significantly affect 
testicular contractions as measured by the presently-used 
technique-- (p > 0.2). 
66 
SUMMARY AND CONCLUSIONS 
The bimodal, stimulating and inhibiting effect of PGE1 on 
testicular contractility alters the reactivity of smooth muscle from 
this preparation to other agents, including PGF2a,acetylcholine and 
epinephrine. At low concentrations of PGE1 (10-lO to 10-
9 M), increased 
stimulation is seen in response to acetylcholine and epinephrine, 
whereas at higher doses (> 10-8 M PGE1), the response to all three 
agents is depressed. The suggested modes of action for PGE1 include 
increased Ca++ influx at low concentrations, but cyclic AMP 
accumulation within the cells at high concentrations. Since prosta-
glandins do occur in rabbit testes, similar effects may occur in the 
1 i v e an i ma 1. 
Both acetylcholine and norepinephrine, which are found respectively 
in the parasympathetic and sympathetic nervous systems, stimulated 
testicular contractions in vivo. Agents that block receptors to these 
neurotransmitters, ho'v1ever, did not reduce l!:!_ vivo testicular 
contractility. Nor did reserpine, a sympatholytic drug, reduce 
contractility. In addition, attempts at stimulating the spermatic 
nerve did not increase testicular tonus or motility. These results 
imply that nerves do not regulate normal testicular contractions. The 
reduction of contractile amplitude and occasional abolition of 
contractions following indomethacin injections ip, support the idea of 
local control by prostaglandins or other agents. The fact that tetraynoic 
acid failed to significantly reduce the amplitude of testicular 
contractions may be attributed to the poor distribution this 
compound achieves in bodily fluids. 
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Nucleotides such as adenosine, and cyclic nucleotides, 
including cyclic GMP, inhibited testicular contractions. 
Testosterone also depressed testicular contractility, especially 
that caused by PGF2a. The stimulation of testicular contractions 
by PGF2a, however, was not altered by alpha-adrenergic blocking 
agents such as dibenamine. Since dibenamine abolished the 
stimulation of testicular tonus increases and contractility 
by catecholamines, one assumes that different receptors are 
present for the PGs and the catecholamines. 
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APPENDIX 
Indomethacin Induces Rat Uterine Contractions 
In Vitro and Alters Reactivity to Calcium and Acetylcholine 
J. L. Hargrove, D. Nesbitt, M. J. Gaspar, L. C. Ellis 
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Abstract 
The initial contractions of uteri in vitro from castrated, 
estrogen-treated rats, were markedly diminished following replacement 
with fresh bathing medium. Indomethacin and aspirin (10-5 to 10-4M)
strongly stimulated such quiescent preparations and reduced their 
b . C 
++ 
su sequent responsiveness to a . Reintroducing the initial bathing 
medium (which contained prostaglandin-like material), or adding 
prostaglandin F2a to the fresh medium, initiated uterine contractions
and restored responsiveness to calcium ion. Injections of indo-
methacin into castrated, estrogen-treated rats reduced initial 
in vitro uterine motility, abolished production of prostaglandin-like 
compounds, and prevented either indomethacin, aspirin or Ca
++ from 
stimulating uterine contractions. Uterine responsiveness to 
acetylcholine � vitro was significantly reduced in rats pretreated 
with indomethacin. 
Prostaglandins are now thought to be major intrinsic regulators 
of uterine contractility. 1 Prostaglandin production may increase
following activation of the uterus by estradiol ,2 and prostaglandin
F2a levels are dependent on the stage of the menstrual cycle in the
human fallopian tube.3 Two established inhibitors of prostaglandin
synthesis, aspirin and indomethacin,4 have been reported to abolish
uterine contractions� vitro.5• 6 They also prolong parturition in
the rat7 and the monkey,8 presumably by blocking endometrial prosta­
glandin synthesis. Salicylates, however, elicit an apparently 
78 
contradictory result--premature parturition in mice. 9 Informal 
reports suggest that aspirin also may precipitate abortion in women 
during early pregnancy.IO 
Prostaglandin production often contributes to spontaneous 
contractions that smooth muscles develop i.!!_ vitro. Adding fresh 
bathing medium may remove these prostaglandins, abolish or reduce 
initial motility, and alter the response of a smooth muscle 
t • l • • d h • l ll prepara ,on to ca c1um 10n an ot er st1mu atory agents. 
Indomethacin affects not only prostaglandin synthesis but also 
calcium balance. 12 We, therefore, investigated the effect of 
changing the Tyrode's solution prior to administering indomethacin, 
aspirin, Ca++ or prostaglandin F2a to rat uterine preparations 
in vitro. We also studied the effects of indomethacin injections 
prior to sacrifice on rat uterine contractility, prostaglandin 
production, and responsiveness to acetylcholine. 
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Materials and Methods 
Two groups of six ovariectomized female rats received 10 µg/kg 
of estradiol benzoate in 0.2 cc of corn oil daily for five days. 
One of the groups also received 10 mg/kg of indomethacin in corn 
oil ip during the final two days and one hour prior to sacrifice. 
The uteri were excised and suspended in all-glass, water-jacketed 
muscle warmers containing 20 ml of oxygenated Tyrode's solution 
(37° C), immediately after the rats had been sacrificed by decapitation. 
Contractions were recorded isometrically against a tension that was 
equivalent to less than 0.5 g. The uteri were incubated for 30 
minutes to allow recovery from thermal or operative shock, and fresh 
medium was added prior to treatment of inactive preparations with 
pharmacological agents. Indomethacin, aspirin, and PGF2a were 
dissolved in ethyl alcohol and added to the bathing media in aliquots 
of 5-100 µl. CaC12 (5 mM) was dissolved in 20 ml of Tyrode
1 s solution 
and put directly into the muscle warmer. 
Two additional groups of four rats were similarly ovariectomized 
and treated with estradiol (10 µg/day for five days); one such group 
received indomethacin (10 mg/kg) on the final two days and one hour 
before sacrifice. Uteri from these animals were suspended in 
Tyrode1 s solution as stated above and used to generate log dose-
response curves in response to acetylcholine (Sigma). 
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Prostaglandin Extraction and Chromatography 
Initial bathing media (20 ml volumes) were collected following 
the 30-minute incubation period and stored at -20° C. Media from 
four preparations of each treatment group (estradiol alone, or 
indomethacin plus estradiol) from above were pooled, acidified to 
pH 3.0 with HCl, and partitioned three times against equal volumes 
of distilled ethyl acetate. The organic solvent was collected and 
dried at 40° C in rotary evaporators. Residues were taken up with 
three 5-ml volumes of ethyl acetate, transferred to 15-ml capacity 
test tubes, and evaporated under nitrogen gas. Lipidic material 
was dissolved in 50 µl of ethanol and spotted on chromatographic 
plates coated with a slurry (0.25 mm thick) of 30 g silica gel H 
(Merck) and 6 g silver nitrate. Plates containing authentic 
prostaglandin were developed with phosphomolybdic acid for confirma-
tion of the Rf values reported by Green and Samuelsson.13 The 
silica gel coat was scraped from the plates on which the extracts 
had been spotted in zones corresponding to these Rf values, 
transferred to centrifuge tubes and eluted three times with 5-ml 
aliquots of methanol to recover any prostaglandin-like material. 
Th• l t th t d d ·t gas at 40° C. 1s so ven was en evapora e un er n, rogen To 
remove salts from the residue, the material was redissolved in 5-ml 
portions of phosphate buffer (pH, 3.0) and partitioned three times 
against equal volumes of ethyl acetate. After evaporating the 
organic solvent, the residues were taken up in Tyrode's solution 
for bioassay on the rabbit testicular capsule as previously 
reported. 14 To estimate the percent recovery of prostaglandins, 
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0.5 µg of PGF1 and 1.0 µg of PGF2a were added to Tyrode's solution; 
this fluid was extracted and chromatographed in the same manner as 
the uterine bath fluid prior to bioassay. 
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Results 
Uteri from estrogen-treated rats contracted autorhythmically 
j_!l vitro at a greater amplitude than those treated with estrogen 
and indomethacin (Table 4). The contractions were markedly 
diminished or totally abolished by a change of the bathing medium, 
but were restored if the original medium was reintroduced 
(Figure 17A and B). Extraction of the original media for acidic 
lipids followed by chromatography and bioassay demonstrated that 
media from estrogen-treated preparations contained prostaglandin-
like material in zones corresponding to authentic prostaglandins 
F2a' Fla' and E1, but not E2. However, indomethacin-pretreated 
preparations were less motile than untreated units, and produced 
no detectable stimulatory material (Table 4). 
The contractile responses of quiescent preparations to aspirin 
or indomethacin proved to be dose-dependent, with a brief stimulation 
followed by tachyphylaxis seen at 10-5 to l0- 4M final concentrations 
(Figure 17C and D). At concentrations greater than 10-4M, both 
aspirin and indomethacin initiated contractions in previously 
inactive preparations (Figure 18A and B): this motility persisted for 
at least 30 minutes in vitro. Replacing the media with fresh 
Tyrode's solution abolished this contractility (data not shown). 
However, when actively-contracting uteri were treated with doses of 
these compounds from 3.5 x 10-5 to 1.4 x 10-4M, neither marked 
stimulation nor inhibition was observed (Figure 18C and D). Inactive 
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Table 4. Initial amplitude of contraction and prostaglandin-like 
material recovered from the bathing media of uteri from 
estradiol-treated (10 µg per day) and estradiol plus 
indomethacin-treated (10 mg per kg) rats. 
Estradiol and 
Estradiol indomethacin p 
(n = 6) (n = 6) 
Initial Contractions 
(g displacement) 1.65 ± 0.37 0.98 ± 0.31 < 0.05 
Prostaglandin-like 
material* (ng per 
20 ml bath fluid) 
PGF2a 320 0 
PGFla 150 0 
PFE2 0 0 
PGE1 30 0 
*Corrected for recovery of 78 percent. Values are given as means 
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Figure 17. A. Reduction of rat uterine contractility 
in vitro following two changes of the bathing 
medium (indicated by arrows). B. Restoration 
of contractility after initial medium from 
an active preparation was added back to 
quiescent preparation (first arrow), with 
reduction in activity after one rinse (second 
arrow). C. Contractions induced by addition 
(at arrow) of 28 wM indomethacin, followed by 
tachphylaxis. D. Contractions in response to 
0.10 mM aspirin (arrow) followed by tachyphylaxis. 
Vertical bar is equivalent to a pen deflection 
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Figure 18. A. Stimulation of inactive rat uterus by 0.14 mM 
indomethacin (added at arrow). B. Stimulation of 
inactive rat uterus by 0.28 mM aspirin (added at 
arrow). C. Lack of inhibition of rat uterine 
contractility following addition (at arrow) of 
0.035 mM indomethacin. D. Lack of inhibition 
of actively contracting rat uterus after addition 
(at arrow) of 0.056 mM aspirin. 
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preparations from indomethacin-pretreated animals responded neither 
to aspirin nor indomethacin with contractions (Table 5). 
Uteri from estradiol-pretreated rats responded to Ca++ with 
increased contractility; this phenomenon was particulary evident in 
qui es cent, rinsed preparations (Figure 19A). However, uteri from 
indomethacin-pretreated rats reacted little to the addition of Ca++ 
to the medium (Figure19B; Table 5). In every case, however, 
7 x l0- 7M PGF2a completely restored uterine responsiveness to Ca++ 
(Figure19C). Ethanol (10-100 µl) did not markedly affect either 
spontaneously active or inactive, rinsed preparations (Figure 190 
and E) . 
Pretreatment of spayed female rats with indomethacin (10 mg/kg) 
prior to sacrifice significantly reduced the responsiveness of 
uterine preparations to acetylcholine (p > 0.05; Figure 20A and C) 
when compared to the response of uteri from control animals. Addition 
of prostaglandin F2a to the media at threshold levels (7 x 10-
9M) 
failed to increase significantly the response to acetylcholine of 
uteri from animals pretreated with indomethacin (p > 0.20; Figure 208). 
Comment 
Nonsteroidal, anti inflammatory drugs may inhibit smooth muscle 
contractility. Northover12 has attributed this effect to an alteration 
b • d h • f C ++ b • d • b b 11 1 b y 1n omet ac,n o a 1n 1ng y su ce u ar mem ranes. Other 
workers have found prostaglandin output to decrease following indo-
h • • • f • d h t • 
5 •6 met ac,n or asp1r1n treatment o rat uterine an ot er prepara ions. 
In addition, cyclic AMP production increases in rat gastric mucosa in 
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Table 5. Contraction frequency (IO-minute interval) of uteri from 
estradiol-treated (10 µg per day) rats versus those from 
estradiol plus indomethacin-treated (10 mg per kg) rats 
in response to stimulation by indomethacin, aspirin and 
CaC12. 
Aspirin 




(1.4 X 10- M)t 
CaC12 (7 mM) 
CaC12 ( 7 mM) + PGF2 (5 X l0-
7M) 
t 0.05 mg/ml 
Estradiol 
( n = 6) 
10. 67 ± 0.88 
8.75 ± 0.63 
9.2 ± 0.80 
14 .1 ± 0. 53 
Estradiol and 
indomethacin 
(n = 6) 
0.5 ± 0.21 
0.0 
0. 83 ± 0. 41 
12.0 ± 0.23 










Figure 19. A. Stimulation of rat uterine contractility by 
7 mM CaC12 ~dded at arrow). B. Lack of effect 
of 7 mM CaC12 (arrow) on quiescent uterus from indomethacin-pretreated rat. C. Lack of effect of 
7 mM CaClz (first arrow) followed by contractions 
induced by addition ~f 71 nM prostaglandin Fza 
(second arrow). D. Slight inhibition of actively-
contracting rat uterus caused by addition of 50 A 
of ethanol (42 mM final concentration) at arrow. 
E. Lack of stimulation of quiescent rat uterus by 
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Figure 20. A. Log dose-response (LOR) curve for the acetylcholine-
caused contraction rate in uteri from estradiol-
pretreated rats. B. LOR curve for acetylcholine 
stimulation of uteri from estradiol- and indomethacin-
pretreated rats, in the presence of 7 nM prostaglandin 
F2a· C. LOR curve depicting the response of uteri 
from estradiol- and indomethacin-pretreated rats to 
acetylcholine. Vertical bars equal ± the standard 
error of the mean. 
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th f • • 15 W h dd. • l • l e presence o asp1r1n. e ere report an a 1t1ona , st,mu atory 
effect of these drugs on smooth muscle contractility, in consonance 
with aspirin's ability to bring about premature parturition in mice. 9 
One plausible cause of increased motility would be a displacement of 
++ 
Ca from subcellular membranes, leading to temporarily high levels 
of unbound, intracellular Ca++. Reduced motility would be expected 
following an efflux of this ion from smooth muscle cells. Our 
observations that uteri from indomethacin-pretreated rats are initially 
quiescent l!:!. vitro, and that these uteri respond to either acetyl-
++ choline or Ca at a low level, accord with such a train of events. 
In a previous report, Vane and Williams6 did not find any change 
in uterine sensitivity to acetylcholine after indomethacin treatment 
in vitro. These workers, however, added the indomethacin directly to 
the uterine bathing medium for brief periods (30-90 sec), whereas 
we injected rats with this compound ip for two days prior to the 
experiment. In addition, their failure to observe increased 
contractility could be due to their use of preparations that were 
already motile as a consequence of prostaglandins present in the 
bathing medium. By first rinsing the uteri with fresh Tyrode's 
solution, we reduced contractility, thereby increasing the sensitivity 
of the preparation to aspirin or indomethacin. Our present results 
h l • d f • t d' 5 , 6 • support t e cone us,on rawn rom previous s u ,es concerning 
the contribution of prostaglandins to smooth muscle motility l!:!. vitro, 
since uteri from rats pretreated with indomethacin produced no 
prostaglandin-like material and were inactive. In addition, 
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prostaglandin F2a always restored uterine contractions and responsive-
++ 6 ness to Ca . Similarly to Vane and Williams, we failed to detect 
any prostaglandin E2 in the media from actively-contracting prepara-
tions, although other PGs were present. However, we found no direct 
inhibition of active uteri by either aspirin or indomethacin. We 
conclude, therefore, that reports of immediately-reduced motility 
may be attributable to rinsing the preparations, thereby removing 
any prostaglandins that may already have been present. Alternatively, 
indomethacin or aspirin may directly inhibit uterine contractions, 
irregardless of the presence of prostaglandins, at the lower 
concentrations used by other researchers. 5• 6 
The evidence presented here suggests that, in addition to 
exerting inhibitory effects on prostaglandin synthesis, indomethacin 
and aspirin directly affect smooth muscle. Observed activation of 
uterine musculature by high doses of antiinflammatory compounds may 
l • h • d • f l b b • d h • • • g' lO exp a,n t e premature 1n uct1on o a or y 1n omet ac,n or asp1r1n, 
while their reported delay of parturition 7• 8 may be due to their 
effects on prostaglandins, cyclic AMP, or Ca++ balance. It now 
seems apparent, in any case, that the actions of indomethacin and 
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